HomeBXP • LON
add
Beximco Pharmaceuticals GDR
Previous close
GBX 36.50
Year range
GBX 33.30 - GBX 45.00
Avg Volume
39.08K
Market news
Financials
Income Statement
Revenue
Net income
(BDT) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 10.90B | 10.24% |
Operating expense | 2.76B | 8.36% |
Net income | 1.43B | 15.88% |
Net profit margin | 13.15 | 5.12% |
Earnings per share | — | — |
EBITDA | 2.63B | 11.03% |
Effective tax rate | 22.08% | — |
Balance Sheet
Total assets
Total liabilities
(BDT) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.73B | 16.97% |
Total assets | 70.63B | 1.89% |
Total liabilities | 21.58B | -8.51% |
Total equity | 49.04B | — |
Shares outstanding | 446.11M | — |
Price to book | 0.00 | — |
Return on assets | 7.63% | — |
Return on capital | 9.34% | — |
Cash Flow
Net change in cash
(BDT) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 1.43B | 15.88% |
Cash from operations | 1.76B | 4.00% |
Cash from investing | -599.98M | 11.88% |
Cash from financing | -1.01B | -57.17% |
Net change in cash | 151.94M | -59.36% |
Free cash flow | 2.33B | 26.94% |
About
Founded
1976
Headquarters
Website
Employees
1,324